Tenax Therapeutics' Phase 3 LEVO-CTS trial in cardiac surgery did not achieve dual endpoint.
In: Chemical Business Newsbase, 2017-01-31
Zeitungsartikel
Zugriff:
Titel: |
Tenax Therapeutics' Phase 3 LEVO-CTS trial in cardiac surgery did not achieve dual endpoint.
|
---|---|
Zeitschrift: | Chemical Business Newsbase, 2017-01-31 |
Veröffentlichung: | 2017 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|